Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-1-21
pubmed:abstractText
BubR1 is an essential mitotic checkpoint protein with multiple functional domains. It has been implicated in mitotic checkpoint control, as an active kinase at unattached kinetochores, and as a cytosolic inhibitor of APC/C(Cdc20) activity, as well as in mitotic timing and stable chromosome-spindle attachment. Using BubR1-conditional knockout cells and BubR1 domain mutants, we demonstrate that the N-terminal Cdc20 binding domain of BubR1 is essential for all of these functions, whereas its C-terminal Cdc20-binding domain, Bub3-binding domain, and kinase domain are not. We find that the BubR1 N terminus binds to Cdc20 in a KEN box-dependent manner to inhibit APC/C activity in interphase, thereby allowing accumulation of cyclin B in G(2) phase prior to mitosis onset. Together, our results suggest that kinetochore-bound BubR1 is nonessential and that soluble BubR1 functions as a pseudosubstrate inhibitor of APC/C(Cdc20) during interphase to prevent unscheduled degradation of specific APC/C substrates.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-10559878, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-10704439, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-11352911, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-11535616, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-11702782, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-11907259, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-11909965, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-12070128, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-12719470, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-12859900, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-1387877, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-15159543, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-15208629, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-15239953, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-15592459, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-15907836, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-16144904, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-16195750, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-16226453, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-16355229, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-16600213, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-16636141, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-16921029, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-17369399, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-17406666, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-17417628, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-17426725, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-17443180, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-17443186, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-17938250, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-18556659, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-19154713, http://linkedlifedata.com/resource/pubmed/commentcorrection/19154723-9858599
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1878-1551
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
118-31
pubmed:dateRevised
2010-12-3
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
BubR1 N terminus acts as a soluble inhibitor of cyclin B degradation by APC/C(Cdc20) in interphase.
pubmed:affiliation
Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural